Comparative analysis of the kinase selectivity profile of masitinib versus other TKIs 25/07/2014 – The knowledge of the selectivity of PKIs is a critical point for the development of optimal safe and well tolerated […] PLoS ONE 2009 Dubreuil – MASITINIB A POTENT c-KIT INHIBITOR 30/09/2009 – Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT Post navigationPreviousPrevious post:Human Medicine – Central Nervous System DiseasesNextNext post:Mast Cells as a TargetRelated PostsHuman Medicine – OncologyJuly 1, 2016Mast Cells as a TargetJanuary 21, 2015Human Medicine – Central Nervous System DiseasesApril 26, 2014Veterinary Medicine – OncologySeptember 22, 2011Veterinary Medicine – Inflammatory diseasesJanuary 1, 2010
